( October 14, 2025, 12:55 PM EDT) -- WASHINGTON, D.C. — The U.S. Supreme Court on Oct. 14 denied a petition for certiorari filed by a stem cell clinic and its owners, who argued that the Ninth Circuit U.S. Court of Appeals erred in finding that a stem cell mixture used by clinics is a drug under the Federal Food, Drug and Cosmetic Act (FDCA)....